The AI in Business Podcast

Today’s guest is Panos Karelis, Director of Customer Experience and Insights at Intelligencia AI. Intelligencia AI is a life sciences technology company that uses proprietary data, biomedical expertise, and AI-driven algorithms to assess the probability of technical and regulatory success for drug candidates, helping pharmaceutical companies make informed decisions on which drugs to advance or discontinue. Panos joins us on today’s show to explore the key challenges and opportunities in AI adoption for drug development. He discusses the “black box” problem in AI and the importance of transparency and explainability in building trust. Panos also highlights the role of high-quality, harmonized data in generating accurate AI-driven insights and the mindset shift required for organizations to integrate AI-assisted decision-making successfully. Additionally, he explains how AI can optimize clinical trial design, enhance portfolio management, and improve business development and licensing decisions. This episode is sponsored by Intelligencia AI. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1.

Join Mark McLaughlin, Director of Insurance at IBM, as he dives into the transformative role of AI in the insurance industry. He discusses the critical challenges insurers face, particularly model bias and the importance of data governance. Mark emphasizes the need for diverse perspectives in AI development to drive equitable outcomes. Discover how a mix of on-premise and cloud strategies is enhancing efficiency and security, enabling insurers to shift from reactive to proactive risk management.

Chris Busch, Founder and CEO of MSTRO, and Yancey Sanford, Founder and Chief of Information and Research at MSTRO, explore the intersection of AI and human reasoning in enterprises. They challenge the narrative of offloading decision-making to AI, emphasizing the irreplaceable value of human intuition and creativity. The duo discusses balancing AI technologies with human insight, the risks of prioritizing immediate returns on AI investments, and the importance of fostering a collaborative approach to enhance productivity and innovation.

Liran Belenzon, Co-founder and CEO of BenchSci, is a trailblazer in applying AI to drug discovery and R&D. He discusses how AI transformations are tackling the complexities of disease biology, paving the way for more efficient workflows. Liran highlights the significance of knowledge graphs and multimodal AI in enhancing research speed and quality. He emphasizes the need for flexible drug discovery processes and the importance of adapting budgets to harness AI’s full potential, balancing innovation with cost-effectiveness.

Oleg Savin, an Enterprise Architect and MES Expert at Unilever, dives into the fascinating world of AI in manufacturing. He highlights the crucial distinctions between neurobiological and cybernetic AI, stressing their unique advantages. Oleg discusses the hurdles manufacturers face in AI adoption and the vital feedback systems that ensure optimal integration. He also explores the differences between autonomy and automation, addressing the social implications of increased automation, particularly in the context of Industry 4.0.

Ken Mertzel, Global Industry Leader at Automation Anywhere, shares his extensive experience in financial services. He highlights the limitations of traditional RPA and discusses the rise of agentic process automation, which enhances decision-making and operational efficiency. Mertzel explains how AI is revolutionizing financial processes such as AML investigations, fraud detection, and underwriting. He emphasizes the importance of interactive systems that leverage advanced data for improved insights, ultimately transforming the way financial organizations operate.

Roenen Ben-Ami, Co-founder and Chief Risk Officer of Justt, dives into the world of chargebacks and the nuances of friendly fraud. He explains how many merchants struggle with the 'guilty until proven innocent' scenario when customers dispute charges. Roenen highlights the innovative use of AI for crafting dynamic arguments that help recover lost funds and maximize win rates. He emphasizes how integrating data sources can streamline the dispute process, offering merchants a lifeline in managing chargebacks more effectively.

Kimberly Powell, Vice President of Healthcare and Life Sciences at NVIDIA, dives into how AI is revolutionizing healthcare. She discusses the critical infrastructure challenges that must be overcome for generative AI to flourish. Imagine hybrid strategies that blend on-premise and cloud solutions, facilitating real-time data for medical imaging! Powell also highlights the exciting potential of AI-driven digital humans that provide 24/7 support to patients, transforming their experience and empowering healthcare staff.

Kartik Pant and Shreyas Becker from Sanofi dive into the evolving landscape of data and AI in life sciences manufacturing. They discuss the critical need for a unified data architecture and the benefits of cloud adoption to enhance collaboration. The duo emphasizes a problem-driven approach to technology, focusing on specific use cases to optimize processes. They also explore the transformative potential of generative AI and how innovative data management solutions can revolutionize operations across the industry. A must-listen for those looking to harness AI in life sciences!

Paul Cuglietta, Head of Contact and Claims at Simplyhealth, shares his wealth of experience in AI integration for digital transformation in healthcare. He discusses how organizations can overcome internal hurdles to enhance AI deployment, highlighting the importance of team collaboration. Paul emphasizes cultivating internal talent to align with AI initiatives and the shifting nature of call center roles, where automation frees staff for complex inquiries. He also stresses the need for empathy and authenticity in customer interactions, enabled by advanced AI solutions.